Literature DB >> 2891276

Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.

G Russ1, K Poláková, F Kostolanský, B Styk, M Vancíková.   

Abstract

Anti-haemagglutinin monoclonal antibodies were prepared and their HA1 or HA2 specificity was determined by solid phase radioimmunoassay (RIA) using purified viral haemagglutinin (HA) and haemagglutinin glycopolypeptides HA1 and HA2, by radioimmunoprecipitation followed with SDS-PAGE, by immunoblotting and by inhibition of virus-induced haemagglutination. The capacity of these methods to estimate HA1 or HA2 specificity of anti-HA monoclonal antibodies (MoAb) was compared. HA1 specificity was demonstrated for all hybridomas originating from lymphocytes of mice immunized with complete influenza virus, except IIF4 hybridoma which was HA2-specific. All hybridomas obtained with lymphocytes from mice immunized with HA glycopolypeptide HA2 were HA2-specific. Anti-HA2 MoAb neither inhibit haemagglutination induced by the virus or by HA subunits nor neutralized viral infectivity, either alone or in mixture. As expected, all anti-HA1 MoAb were H3 subtype-specific, showing usually good reactivity only with viruses close to the virus strain used for immunization. Two anti-HA1 MoAb (IVA1 and IVG6) showed unusual cross-reactivity within the H3 subtype. All anti-HA2 MoAb were broadly cross-reactive within the H3 subtype. Moreover, a half of them showed high cross-reactivity with influenza viruses of the H7 HA subtype. But the same antibodies did not react with HA of H1, H2 and H8 subtypes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891276

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  12 in total

1.  Evaluation of the subtype specificity of monoclonal antibodies raised against H1 and H3 subtypes of human influenza A virus hemagglutinins.

Authors:  Eva Varecková; Nancy Cox; Alexander Klimov
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Epitope specificity of anti-HA2 antibodies induced in humans during influenza infection.

Authors:  Zuzana Staneková; Vojtech Mucha; Tatiana Sládková; Hana Blaškovičová; František Kostolanský; Eva Varečková
Journal:  Influenza Other Respir Viruses       Date:  2012-01-12       Impact factor: 4.380

3.  Conservation of epitopes recognized by monoclonal antibodies against the separated subunits of influenza hemagglutinin among type A viruses of the same and different subtypes.

Authors:  A Sanchez-Fauquier; M Guillen; J Martin; A P Kendal; J A Melero
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules.

Authors:  E Varecková; V Mucha; F Ciampor; T Betáková; G Russ
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  A highly conserved neutralizing epitope on group 2 influenza A viruses.

Authors:  Damian C Ekiert; Robert H E Friesen; Gira Bhabha; Ted Kwaks; Mandy Jongeneelen; Wenli Yu; Carla Ophorst; Freek Cox; Hans J W M Korse; Boerries Brandenburg; Ronald Vogels; Just P J Brakenhoff; Ronald Kompier; Martin H Koldijk; Lisette A H M Cornelissen; Leo L M Poon; Malik Peiris; Wouter Koudstaal; Ian A Wilson; Jaap Goudsmit
Journal:  Science       Date:  2011-07-07       Impact factor: 47.728

6.  Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2.

Authors:  F Kostolansky; G Russ; V Mucha; B Styk
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

7.  Evaluation of monoclonal antibodies for subtyping of currently circulating human type A influenza viruses.

Authors:  M Tkácová; E Varecková; I C Baker; J M Love; T Ziegler
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

Review 8.  Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development.

Authors:  Zuzana Staneková; Eva Varečková
Journal:  Virol J       Date:  2010-11-30       Impact factor: 4.099

9.  Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.

Authors:  Reiko Yoshida; Manabu Igarashi; Hiroichi Ozaki; Noriko Kishida; Daisuke Tomabechi; Hiroshi Kida; Kimihito Ito; Ayato Takada
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

10.  Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.

Authors:  Angeline P C Lim; Conrad E Z Chan; Steven K K Wong; Annie H Y Chan; Eng Eong Ooi; Brendon J Hanson
Journal:  Virol J       Date:  2008-10-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.